- Home
- AGL vs SLP Comparison
AGL vs SLP Comparison
Compare AGL & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGL
- SLP
- Stock Information
- Founded
- AGL 2016
- SLP 1996
- Country
- AGL United States
- SLP United States
- Employees
- AGL N/A
- SLP N/A
- Industry
- AGL Managed Health Care
- SLP EDP Services
- Sector
- AGL Health Care
- SLP Technology
- Exchange
- AGL Nasdaq
- SLP Nasdaq
- Market Cap
- AGL 276.6M
- SLP 322.4M
- IPO Year
- AGL 2021
- SLP 1997
- Fundamental
- Price
- AGL $0.64
- SLP $17.29
- Analyst Decision
- AGL Hold
- SLP Buy
- Analyst Count
- AGL 17
- SLP 7
- Target Price
- AGL $2.79
- SLP $26.80
- AVG Volume (30 Days)
- AGL 12.8M
- SLP 389.0K
- Earning Date
- AGL 11-04-2025
- SLP 01-06-2026
- Dividend Yield
- AGL N/A
- SLP N/A
- EPS Growth
- AGL N/A
- SLP N/A
- EPS
- AGL N/A
- SLP N/A
- Revenue
- AGL $5,885,571,000.00
- SLP $80,383,000.00
- Revenue This Year
- AGL N/A
- SLP $13.67
- Revenue Next Year
- AGL $5.76
- SLP $1.50
- P/E Ratio
- AGL N/A
- SLP N/A
- Revenue Growth
- AGL 5.21
- SLP 20.01
- 52 Week Low
- AGL $0.51
- SLP $12.39
- 52 Week High
- AGL $6.08
- SLP $37.67
- Technical
- Relative Strength Index (RSI)
- AGL 38.45
- SLP 52.74
- Support Level
- AGL $0.51
- SLP $16.03
- Resistance Level
- AGL $0.86
- SLP $17.55
- Average True Range (ATR)
- AGL 0.07
- SLP 0.71
- MACD
- AGL 0.00
- SLP -0.14
- Stochastic Oscillator
- AGL 33.50
- SLP 57.90
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.